:

Jie Liu1, Wensi Gao2, Xiong Zheng1

  • 1Department of Head and Neck Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

Frontiers in endocrinology
|February 10, 2025
PubMed
概括

分子检测可以识别高风险的差异化甲状腺癌与与复发相关的遗传改变. 这种方法完善了风险分层,指导个性化的随访和治疗,以获得更好的患者结果.